SudhakarTummalaMD
Neurology • Little Rock, AREpilepsy, Neuromuscular Medicine, Neurophysiology
Physician
Are you Dr. Tummala?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Connect with colleagues in the same hospital or clinic
You already have 53 invites waiting! - Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
2 Saint Vincent Cir
Little Rock, AR 72205Phone+1 501-552-3000- Is this information wrong?
Summary
- Dr. Sudhakar Tummala, MD is a board certified neurologist in Little Rock, Arkansas. He is currently licensed to practice medicine in Arkansas, Georgia, and Mississippi. He is affiliated with University of Texas M.D. Anderson Cancer Center.
Education & Training
University of Texas Health Science Center at HoustonFellowship, Clinical Neurophysiology, 2002 - 2003
Baylor College of MedicineResidency, Neurology, 1998 - 2001
Jersey Shore University Medical CenterResidency, Internal Medicine, 1995 - 1998
Guntur Medical College NTRClass of 1993
Certifications & Licensure
FL State Medical License 2021 - Present
AZ State Medical License 2023 - 2025
WA State Medical License 2023 - 2025
GA State Medical License 2023 - 2024
MS State Medical License 2023 - 2024
OK State Medical License 2020 - 2024
AR State Medical License 2023 - 2024- American Board of Internal Medicine Internal Medicine
- American Board of Psychiatry and Neurology Neurology
- American Board of Psychiatry and Neurology Clinical Neurophysiology
- American Board of Psychiatry and Neurology Epilepsy
- American Board of Psychiatry and Neurology Neuromuscular Medicine
- Join now to see all
Publications & Presentations
PubMed
- Intraoperative language mapping guided by real-time visualization of gamma band modulation electrocorticograms: Case report and proof of concept.Noll, K., Asman, P., Tasnim, I., Hall, M., Connelly, K., Swamy, C., Ene, C., Tummala, S., Grasu, R., Liu, H., Kumar, V., Muir, M., Prinsloo, S., Michener, H., Wefel, J...> ;Neuro-Oncology Practice. 2024 Feb 1
- Efficacy and safety of brexucabtagene autoleucel CAR T-cell therapy with BTK inhibitors in the treatment of relapsed mantle cell lymphoma with central nervous system i...Fetooh, A., Nair, R., Malpica, L., Wang, M., Lionel, A., Gurumurthi, A., Eldaya, R., Ahmed, S., Iyer, S., Nastoupil, L., Westin, J., Fayad, L., Tummala, S., Flowers, C...> ;Leukemia & Lymphoma. 2024 Jan 22
- Immune-checkpoint inhibitors and neurological adverse events.Sudhakar Tummala> ;The Lancet. Neurology. 2023 Dec 1
- Join now to see all
Press Mentions
Management of a Patient with Mantle Cell Lymphoma Who Developed Severe Neurotoxicity After Chimeric Antigen Receptor T-cell Therapy in ZUMA-2October 16th, 2020
'In Sickness and in Health': Couple Weds After Both Surviving Cancer DiagnosesOctober 24th, 2019
Cancer Patients with Rare Deadly Brain Infection Treated Successfully with Off-the-Shelf Adoptive T-cell Therapy in Clinical TrialOctober 11th, 2018- Join now to see all
Professional Memberships
- Member
Hospital Affiliations
University of Texas M.D. Anderson Cancer CenterHouston, Texas
